Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
about
Functional anatomy of movement disordersBrain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.Animal models of generalized dystonia.Neuromelanin in the human brain: a review and atlas of pigmented cells in the substantia nigra.Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate.Brainstem motor loops in the control of movement.A new quantitative rating scale for dyskinesia in nonhuman primates.Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.Non-human primate models of PD to test novel therapies.Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate.The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys.Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa.Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.Mso Prize for Young Pharmacologist: Striatal outputs and dyskinesia.Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment.
P2860
Q24544908-02669AB6-7249-47FD-83C7-5EF83E881618Q30833645-B15A3792-7485-4BB8-962C-289A69F36656Q33844755-59A606D2-31E3-4E53-B134-C32D0339909BQ34169019-4BD377E2-441B-4F60-A84F-106768D43B26Q34214529-BC70DB47-284A-415B-9FB6-93EAB176A540Q34596334-F9DCCD06-C9DF-4995-BEEA-7208D40F61F2Q34771498-A560043A-1DB6-4FAB-9D6F-F5FF54AEED98Q35589979-B2C550A4-0F5B-4B74-A740-804090A25B20Q37585084-917C720A-F56D-45E4-8F4A-EEFEDA32B3FEQ39229450-AA9A5C17-BEB3-43D5-B7F2-F605BC89CF15Q41738298-E319422C-829B-4E17-A577-888EA593ACABQ41827887-1CF57F72-3A2C-42E5-8062-259EDD78264DQ44165234-6C515912-42DA-454B-AD9B-8065D6889760Q44237901-571011AD-2A98-4371-8FCC-E0CE7A8A3640Q44423669-C793735C-2824-41D2-B962-291821FDE8EAQ48171351-2D5BF278-CE29-4108-B60A-F7E0B3E61936Q48405174-26F44BF8-67B2-4B4B-B764-F5F0C40E98C0Q48880549-3B45F513-6491-48E6-BAB6-07F66CBC9F9A
P2860
Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Levodopa-induced dyskinesia an ...... 3,6-tetrahydropyridine (MPTP).
@en
Levodopa-induced dyskinesia an ...... 3,6-tetrahydropyridine (MPTP).
@nl
type
label
Levodopa-induced dyskinesia an ...... 3,6-tetrahydropyridine (MPTP).
@en
Levodopa-induced dyskinesia an ...... 3,6-tetrahydropyridine (MPTP).
@nl
prefLabel
Levodopa-induced dyskinesia an ...... 3,6-tetrahydropyridine (MPTP).
@en
Levodopa-induced dyskinesia an ...... 3,6-tetrahydropyridine (MPTP).
@nl
P2093
P921
P1476
Levodopa-induced dyskinesia an ...... 3,6-tetrahydropyridine (MPTP).
@en
P2093
Crossman AR
Mitchell IJ
Sambrook MA
P304
P356
10.1016/0022-510X(87)90041-4
P577
1987-05-01T00:00:00Z